Web-Based Intervention Designed to Educate and Improve Adherence Through Learning to Use Continuous Glucose Monitoring

University of Florida1 site in 1 country8 target enrollmentMarch 9, 2018

ConditionsType 1 Diabetes Mellitus Continuous Glucose Monitor

Overview

Phase: N/A
Intervention: Not specified
Conditions: Type 1 Diabetes Mellitus
Sponsor: University of Florida
Enrollment: 8
Locations: 1
Primary Endpoint: Adherence to CGM
Status: Completed
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The goal of this pilot study is to produce a high-quality, theory-driven, therapeutic, web-based intervention that provides extended training and peer support to adolescents and young adults with type 1 diabetes who are newly implementing CGM. Overall, this web-based intervention represents an efficient way to bring together professionally-supported CGM educational materials and social support to overcome known barriers and address factors associated with inconsistent CGM use.

Registry

clinicaltrials.gov

Start Date

March 9, 2018

End Date

November 1, 2018

Last Updated

7 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

University of Florida

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Ability to read and speak English
•Diagnosed with type 1 diabetes (T1D) for \> 3 months before consent is obtained
•Aged \>15 years and \<24 years at time of enrollment
•Must have access to a smartphone, tablet or laptop/desktop computer with high speed internet access and speaker
•Must be using/initiating a Dexcom CGM

Exclusion Criteria

•Cognitive or learning disability (e.g., inability to read) that would preclude their ability to comply with the study protocol
•Significant medical comorbidity in the adolescent or young adult that could, in the opinion of the PI, affect subject's capacity to follow study protocol
•Previous use of a CGM within the last 3 months
•Unwilling or unlikely to return to clinic for a follow-up HbA1c test
•Unwillingness to accept randomization